Mass-spectrometry-based functional proteomic and phosphoproteomic technologies and their application for analyzing ex vivo and in vitro models of hypertrophic cardiomyopathy

HIGHLIGHTS

• who: Jarrod Moore and Andrew Emili from the Center for Network Systems Biology, Boston University School of Medicine, Boston, MA, USA have published the research: Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy, in the Journal: (JOURNAL) of 15/Nov/2021
• what: In this review the authors evaluate state-of-the-art and technologies and their application to in vitro and ex vivo models of HCM for global mapping of macromolecular alterations driving disease progression emphasizing their potential for defining the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.